MRNA vs ROOT · rev $1.94B vs P/E 14, rev $1.18B
Moderna Inc (MRNA) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
MRNA currently screens at market cap $24.52B. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the MRNA and ROOT stock pages for the full models.
Not investment advice.